MAPK3 and colorectal carcinoma: In addition, the upstream activators of MEK, namely RAS and RAR, often undergo gain-of-function mutations that make them constitutively active in CRC, and these constitutively activated signals pass to ERK1/2 through MEK1/2 [22].